Dr. Reddy’s Labs (RDY), Merck Serono Enter Biosimilar Compound Development Agreement
Tweet Send to a Friend
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today a partnership ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
